ReadyCell is pleased to participate in the XV meeting of the Spanish Drug Discovery Network (SDDN) at the Parc de Recerca Biomèdica de Barcelona (PRBB) on November 20th and 21st, 2023.
The meeting focused on exploring the current market dynamics and emerging trends in the field of cell culture technology and drug discovery. Both companies, ReadyCell and OYC, are committed to providing their customers with top-tier products and services.
From October 24th to 26th, members of ReadyCell’s Business Development (BD), Research and Development (R&D), and Marketing departments attended the CPHI Barcelona 2023 Congress.
During his talk, he explored the essence of innovation, its various forms, and its crucial role in driving growth and success.
Lourdes Gombau, head of the R&D Department, and Maria Riba, Business Development Manager, presented in the UK the last scientific article of the company, shedding light on the topic of compound intestinal toxicity.
On May 15-17, the 22nd Barrier- and Transporter- days took place in Germany. At the event, Jonatan Cucala, R&D researcher at ReadyCell, presented a poster entitled “PreadyTake, an in vitro ready-to-use cell-based model to evaluate potential drug-transporter interactions.”
